Evidence map›Paper›PMID 36708403›Full record

ArticleInternational urogynecology journal2023

Nocturnal polyuria in women: results from the EpiNP study.

Elizabeth R Mueller, Jeffrey P Weiss, J L H Ruud Bosch, Bilal Chughtai, Matt T Rosenberg, Elizabeth D Bacci, Jason C Simeone, Fredrik L Andersson, Kristian Juul, Karin S Coyne and 1 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in International urogynecology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04125186 (Epidemiology and Burden of Nocturia Due to Nocturnal Polyuria in the United States), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04125186 completednot on this map

Epidemiology and Burden of Nocturia Due to Nocturnal Polyuria in the United States: The EpiNP Study

TypeobservationalSponsorFerring PharmaceuticalsRan2019 to 2020Enrolled10,190ConditionsNocturnal PolyuriaArmsBaseline EpiNP survey, Bladder diary, Testing of EpiNP baseline survey, bladder diary and a qualitative interview, No other intervention
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 4 countries.

Elizabeth R MuellerLoyola University, Maywood, IL, USA.
Jeffrey P WeissSUNY Downstate Health Sciences University, Brooklyn, NY, USA.
J L H Ruud BoschFranciscus G&V Hospital, Rotterdam, Netherlands.
Bilal ChughtaiWeill Cornell Medicine, New York, NY, USA.
Matt T RosenbergMid Michigan Health Center, Jackson, MI, USA.
Elizabeth D BacciEvidera, Seattle, WA, USA.
Jason C SimeoneEvidera, Waltham, MA, USA.
Fredrik L AnderssonFerring Pharmaceuticals A/S, Copenhagen, Denmark.
Kristian JuulFerring Pharmaceuticals A/S, Copenhagen, Denmark.
Karin S CoyneEvidera, 7101 Wisconsin Avenue, Suite 1400, Bethesda, MD, 20814, USA. karin.coyne@evidera.com.
Christopher R ChappleUniversity of Sheffield, Sheffield, UK.
Ferring Pharmaceuticals (Denmark) · DKIthaka Harbors · USCornell University · USLoyola University Chicago · USSeattle University · USSint Franciscus Gasthuis · NLSUNY Downstate Health Sciences University · USUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisData from a large US population-based, cross-sectional, epidemiological study (the EpiNP Study) were used to assess the symptoms and bother experienced by women with nocturnal polyuria (NP).

methodsConsenting participants recruited from an online panel completed the baseline EpiNP survey online (Lower Urinary Tract Symptoms Tool and urological comorbidities). All reporting ≥2 voids/night and a random sample of 100 respondents, each reporting 0 or 1 void/night were asked to complete a 3-day web-based bladder diary recording time, volume, and urgency rating of each void. NP was calculated by the proportion of urine production that occurred during nocturnal hours using a Nocturnal Polyuria Index (NPI33) threshold of >0.33 or nocturnal urine production of >90 ml/h (NUP90). The frequency of participants reporting LUTS and bother was determined by age and NP: idiopathic NP, NP associated with overactive bladder (NPOAB), NP associated with comorbidities (NPCom), and no NP (did not meet NP criteria).

resultsA total of 5,290 women completed the baseline survey. Mean age (range) was 54.9 (30-95) years; 1,841 (34.8%) reported ≥2 nocturnal voids. The prevalence of LUTS increased across the lifespan; however, bother associated with each LUTS decreased with increasing age. The percentage of women rating bother by nocturia episodes ≥2 "> somewhat" ranged from 40.3% to 68.3%, with bother ratings highest in the NPOAB and No NP groups.

conclusionsNP is prevalent in women with considerable bother and is often associated with other urinary symptoms. Multifactorial causes and potential treatments of NP should be considered, particularly at a later age.

Indexed as

Lower Urinary Tract SymptomsNocturiaUrinary Bladder, OveractiveCross-Sectional StudiesFemaleHumansMiddle AgedPolyuriaCross-sectional surveyEpidemiologyNocturiaNocturnal polyuriaPrevalenceWomen

Identifiers

PMID36708403
OpenAlexW4318340546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.